Intas to launch its first biosimilar in US in 9-12 months

21-Jun-2015 #Healthcare & Pharma Source: DNA India
Intas pharmaceuticals is expected to launch its first biosimilar in the US within the next 9-12 months out of the two biosimilars filed for registration in the US. Intas is the only company from India to have a biosimilar in European market.
Read Full Article..
Tagged: , ,
Array
(
    [0] => post-template-default
    [1] => single
    [2] => single-post
    [3] => postid-7644
    [4] => single-format-standard
    [5] => do-etfw
    [6] => wpb-js-composer js-comp-ver-3.6.14.1
    [7] => vc_responsive
)
7644false